By Reuters U.S. biotech company Novavax Inc has joined the race to test coronavirus vaccine candidates on humans and said it was targeting production of over a billion doses of its vaccine candidate next year. The company, which enrolled its first participants on Monday, said it expected preliminary data on safety and indicators of an […]
- Categories:
- FISM News